Label expansion strategy -- The company is actively pursuing a broad label for Tadaraben to include all Stargardt disease patients aged 12 and older based on regulator feedback and clinical similarity ...
Operator: Ladies and gentlemen, thank you for joining us, and welcome to Sportradar Group AG's fourth quarter earnings call. Hello everyone, thank you for joining us for Sportradar Group AG's earnings ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results